Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)

Olivier Thaunat

Unité De Formation Et De Recherche Lyon Est, 
EE 
Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)
Unité De Formation Et De Recherche Lyon Est, 
EE 
OverviewLocationsClinical Research

Overview

Olivier Thaunat practices in Estonia. Mr. Thaunat is rated as an Experienced expert by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Chronic Kidney Disease, Kidney Transplant, and Pancreas Transplant.

His clinical research consists of co-authoring 176 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Multisystem Inflammatory Syndrome in Children (MIS-C).

Gender
Male

Locations

Unité De Formation Et De Recherche Lyon Est, Estonia
Other Locations
44 Lincoln's Inn Fields, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of a Strategy Based on the 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation: the I4BiS Study
Evaluation of a Strategy Based on the 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation: the I4BiS Study
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Other, Drug
Study Drug: Corticosteroid boluses Methylprednisolone
Study Phase: Phase 3
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T
Enrollment Status: Completed
Publish Date: June 07, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

175 Total Publications

Expanding the clinical spectrum of lysozyme-derived amyloidosis.
Expanding the clinical spectrum of lysozyme-derived amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thaunat's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile